Autonomix Medical, Inc.
AMIX
$0.40
$0.013.01%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -21.12% | -68.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.13% | -55.63% | |||
| Operating Income | 18.13% | 55.63% | |||
| Income Before Tax | 18.25% | 56.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 18.25% | 56.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 18.25% | 56.23% | |||
| EBIT | 18.13% | 55.63% | |||
| EBITDA | 18.12% | 55.67% | |||
| EPS Basic | 35.54% | 73.55% | |||
| Normalized Basic EPS | 35.54% | 73.55% | |||
| EPS Diluted | 35.54% | 73.55% | |||
| Normalized Diluted EPS | 35.54% | 73.55% | |||
| Average Basic Shares Outstanding | 26.86% | 65.49% | |||
| Average Diluted Shares Outstanding | 26.86% | 65.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||